An Integrative Review to Progress the Responsible Development of Nano-Drugs

There has been extensive research on improving and innovating current treatments for irritable-bowel-syndrome using nanotechnology. However, there are growing challenges to progress these drugs to clinical trials and commercialisation. This study sought to develop a framework to manage key features, overlooked in current studies, to improve the development of drugs. An integrative literature review was used to extract themes by using a summative content analysis to interrogate information. Validity was established when saturation of information was achieved. Reliability focussed on the repeatability of key information. Absorption, distribution, metabolism, excretion and toxicity, quality by design attributes, metrology, and standardisation of practice emerged as important themes. These themes together among others, were used to develop the framework to manage the drug development process: Knowledge-based society, Foresight planning, Multidisciplinary approach, Unified definition, Adapt to existing standards and guidelines, Precautionary principle, Case-by-case approach, Quality-by-design, Scale-up and Training. The framework provided reflections that no study has considered. The framework will ensure that drug development will be approached strategically to avoid duplication of research-designs, including risk mitigation, quality at the source and supplier-chain management to progress drug development to clinical trials and beyond.

• Publication year

  2023

• Venue

  African Journal of Inter-Multidisciplinary Studies

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.51415/ajims.v5i1.1114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Challenge and Development Strategy for Colon-Targeted Drug Delivery System

  2022influential reference
• Structure-Property Relationship for Different Mesoporous Silica Nanoparticles and its Drug Delivery Applications: A Review

  2022influential reference
• Natural polysaccharides and proteins applied to the development of gastroresistant multiparticulate systems for anti-inflammatory drug delivery – A systematic review

  2022cited by this paper
• A nanotechnology-foresight perspective of South Africa

  2021cited by this paper
• Drug delivery to the inflamed intestinal mucosa- targeting technologies and human cell culture models for better therapies of IBD.

  2021influential reference
• The SERENADE project; a step forward in the safe by design process of nanomaterials: The benefits of a diverse and interdisciplinary approach

  2021cited by this paper
• Micro and nanoscale technologies in oral drug delivery

  2020influential reference
• Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences.

  2020influential reference
• Public perception and knowledge on nanotechnology: A study based on a citizen science approach

  2020influential reference
• Ulcerative colitis: A review on drug delivery strategies

  2020cited by this paper
• Why Science Communication, and Does It Work? A Taxonomy of Science Communication Aims and a Survey of the Empirical Evidence

  2019cited by this paper
• QbD-Based Development of Cationic Self-nanoemulsifying Drug Delivery Systems of Paclitaxel with Improved Biopharmaceutical Attributes

  2019cited by this paper
• Moving policy and regulation forward for nanotechnology applications in agriculture

  2019cited by this paper
• Literature review as a research methodology: An overview and guidelines

  2019influential reference
• Nanoethics, Science Communication, and a Fourth Model for Public Engagement

  2017cited by this paper
• Design and Characterization of Mesalamine Loaded Nanoparticles for Controlled Delivery System

  2016cited by this paper
• Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?

  2016cited by this paper
• Advances in the treatment of inflammatory bowel disease

  2016influential reference
• Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.

  2015cited by this paper
• A quality by design approach to understand formulation and process variability in pharmaceutical melt extrusion processes

  2015cited by this paper
• Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics

  2015cited by this paper
• Nanotechnology in the treatment of inflammatory bowel diseases.

  2014cited by this paper
• Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach.

  2013cited by this paper
• Nanosafety in Europe 2015-2020: Towards Safe and Sustainable Nanomaterials and Nanotechnology Innovations

  2013cited by this paper
• Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies

  2012cited by this paper
• Evaluating the quality of standard samples of nanomaterials based on a risk analysis for nonconformity

  2012influential reference
• Synthesis and characterization of temperature sensitive hemicellulose-based hydrogels

  2011cited by this paper
• Research methodology: an introduction

  2011cited by this paper
• Integrative review: what is it? How to do it?

  2010cited by this paper
• Some key emerging food safety issues

  2010influential reference
• Nanoparticle analysis and characterization methodologies in environmental risk assessment of engineered nanoparticles

  2008cited by this paper
• Extraction of valuable compounds from the flavedo of Citrus junos using subcritical water

  2008cited by this paper
• 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.

  2007influential reference
• Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.

  2002cited by this paper
• Technical analysis of ISO/DIS 17025-general requirements for the competence of testing and calibration laboratories

  1999cited by this paper

• No citing papers are available for this paper.